Welcome to the Scholars Journal of Drug Design and Drug Discovery
The Scholars Journal of Drug Design and Drug Discovery is a cutting-edge, peer-reviewed publication dedicated to advancing the science of drug design, molecular pharmacology, and therapeutic innovation. Our journal brings together a global community of researchers, scientists, and healthcare professionals to explore the latest developments in drug discovery, from early-stage design to clinical application. We focus on publishing high-quality research that offers novel insights into the drug development process, including molecular modelling, bioinformatics, and structure-based drug design. By providing a platform for innovative and interdisciplinary research, we aim to accelerate the discovery of new, effective therapies that address unmet medical needs.
Our journal features research on a wide variety of topics, including computational drug design, biologics, small molecules, and emerging technologies in the pharmaceutical field. We strive to offer a space where novel methodologies, techniques, and findings can be shared, advancing the pharmaceutical sciences to improve patient outcomes globally. Whether you are a researcher, student, or industry professional, the Drug Design and Drug Discovery Journal is a valuable resource for staying at the forefront of drug development.
Aim:
The Scholars Journal of Drug Design and Drug Discovery aims to publish innovative research that advances the field of drug discovery. Our goal is to provide a collaborative platform for the exchange of ideas, cutting-edge methodologies, and breakthroughs in therapeutic development. We focus on fostering advancements in drug design, molecular pharmacology, and treatment strategies that will have a meaningful impact on healthcare and the pharmaceutical industry.
Scope:
The Scholars Journal of Drug Design and Drug Discovery covers a wide range of topics within the drug development field, including but not limited to computational drug design, medicinal chemistry, pharmacodynamics, bioinformatics, and drug resistance. We welcome original research, reviews, and opinion articles that contribute to the understanding and application of drug design techniques, as well as innovative approaches to discovering new therapeutic agents for various diseases.
